/ PFE
/ Market Analysis
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.
December 17, 2024
Pfizer Inc.’s Strong Q3 Performance: Beats Expectations with $1.06 EPS
Pfizer Inc. reported stellar third-quarter financial results, with revenues surging to $17.7 billion.
October 29, 2024
Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%
Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer.
October 07, 2024
Pfizer Inc. (PFE) Beats Q2 Market Expectations with $13.3 Billion in Revenue
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion.
July 30, 2024
Stocks to Watch Today: Delta Air Lines, Tesla, and Pfizer
Major market movers today include Delta Air Lines tumbling on weak guidance, Tesla falling amid a debate over its stock performance, and Pfizer rising on development news.
July 11, 2024
Back to 
